Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GivaudanSTU:GIN1 +0.74%86 EBITDA Margin % is 21.69% as of Jun. 2026, which is 2% above its 10-year median of 21.29. GuruFocus rates STU:GIN1 with a GF Score™ of 86/100 and a GF Value™ of €79.84 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 1,579 Chemicals companies, Givaudan ranks better than 86.64% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Givaudan's EBITDA for the
six
months ended in Jun. 2026 was €895 Mil. Givaudan's Revenue for the
six
months ended in Jun. 2026 was €4,126 Mil. Therefore, Givaudan's EBITDA margin for the quarter that ended in Jun. 2026 was 21.69%.
Givaudan (STU:GIN1) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Givaudan EBITDA Margin % Related Terms
Givaudan EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Givaudan's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:GIN1 vs LIN, SHW, ECL: EBITDA Margin % Comparison
For the Specialty Chemicals subindustry, Givaudan's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Givaudan EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Givaudan's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Givaudan's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Givaudan (STU:GIN1) has a EBITDA Margin % of 21.69% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Givaudan and its competitors. This is near median its historical median of 21.29. Over the past decade, Givaudan's EBITDA Margin % has ranged from 19.52 to 24.19. According to the industry distribution chart, Givaudan ranks #211 out of 1579 companies in the Chemicals industry, placing it in the top 13.4%.
Is Givaudan's EBITDA Margin % too high?
Givaudan's current EBITDA Margin % of 21.69% is near median its 10-year median of 21.29. Over the past 10 years, this metric has ranged from a low of 19.52 to a high of 24.19. The Chemicals industry median EBITDA Margin % is 9.64. Givaudan's value of 21.69% is 125% above this industry median. Based on the distribution chart, Givaudan ranks #211 out of 1579 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Givaudan has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Givaudan's EBITDA Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Givaudan ranks #211 out of 1579 companies for EBITDA Margin %. This places Givaudan in the top 13% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 9.64. Givaudan's value of 21.69% is 125% above this benchmark. Historically, Givaudan's own EBITDA Margin % has ranged from 19.52 to 24.19 over the past decade. While the company's 10-year median is 21.29 vs. the industry median of 9.64, Givaudan has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.64, based on 1,579 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Givaudan's current EBITDA Margin % of 21.69% is 125% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Givaudan and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Givaudan's current EBITDA Margin % is 21.69%, which is near median its own 10-year median of 21.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Givaudan stock overvalued right now?
Based on GuruFocus' analysis, Givaudan (STU:GIN1) is currently considered Modestly Undervalued. The stock's GF Value™ is €79.84, compared to a current price of €68.50 — trading 14.2% below its estimated fair value. The current EBITDA Margin % is 21.69%, which is near median its 10-year median of 21.29 and 125% above the Chemicals industry median of 9.64. Givaudan's overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Givaudan (STU:GIN1), the current EBITDA Margin % is 21.69% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Givaudan (STU:GIN1) Overvalued in 2026?
Based on GuruFocus' analysis, Givaudan stock appears to be undervalued.
The current stock price of €68.50 is trading 14.2% below its estimated GF Value™ of €79.84.
GuruFocus considers Givaudan to be Modestly Undervalued.
Key valuation signals for STU:GIN1:
EBITDA Margin %: 21.69% (near median its 10-year median of 21.29)
GF Value™: €79.84 vs. price of €68.50 (14.2% below fair value)
Industry Position: 125% above the Chemicals median (#211 of 1579)
No single metric tells the full story. See the STU:GIN1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Spun off from Roche in 2000, Givaudan is one of the world's leading flavor and fragrance manufacturers, with a presence in more than 80 countries. It sources more than 11,000 different ingredients from over 100 countries. The company serves end consumer markets with fragrances for personal, home, and laundry care brands, including prestige perfumes. In flavors, customers are in beverages, savory, snacks, sweet goods, and dairy. Givaudan has more than 17,000 employees, and its perfumery team is the largest in the industry.
86GF Score
Get the complete analysis for STU:GIN1
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:GIN1 has been successfully added to your 
